Paper30680929
Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
Hu S and 7 others. J Cell Mol Med, 2019. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. Papers, record 30680929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30680929
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin II | Major topic |
| Aorta | Major topic |
| Cardiomegaly | Major topic |
| MicroRNAs | Major topic |
| Myocytes, Cardiac | Major topic |
| Myosin-Light-Chain Kinase | Major topic |
| Animals | |
| Antagomirs | |
| Apoptosis | |
| Constriction, Pathologic | |
| Disease Models, Animal | |
| Echocardiography | |
| Gene Expression Regulation | |
| Male | |
| Oligoribonucleotides | |
| Primary Cell Culture | |
| Rats | |
| Rats, Sprague-Dawley | |
| Reactive Oxygen Species | |
| Signal Transduction |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 37395337 | Correction to Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. | https://conductscience.org/library/papers/37395337 |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26497329 | Glucose Fluctuations Aggravate Cardiac Susceptibility to Ischemia/Reperfusion Injury by Modulating MicroRNAs Expression. | Circ J | 2016 | https://conductscience.org/library/papers/26497329 | PubMed |
| 2 | 30680929 | Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30680929 | PubMed |
| 3 | 21527937 | miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. | Cell Death Differ | 2011 | https://conductscience.org/library/papers/21527937 | PubMed |
| 4 | 17804704 | Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. | Cancer Res | 2007 | https://conductscience.org/library/papers/17804704 | PubMed |
| 5 | 21345328 | The significance of regulatory light chain phosphorylation in cardiac physiology. | Arch Biochem Biophys | 2011 | https://conductscience.org/library/papers/21345328 | PubMed |
| 6 | 28700997 | Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress. | Cell Physiol Biochem | 2017 | https://conductscience.org/library/papers/28700997 | PubMed |
| 7 | 28494450 | Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy. | Cell Physiol Biochem | 2017 | https://conductscience.org/library/papers/28494450 | PubMed |
| 8 | 29262413 | Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy. | Cell Physiol Biochem | 2017 | https://conductscience.org/library/papers/29262413 | PubMed |
| 9 | 24481846 | Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. | Circ Res | 2014 | https://conductscience.org/library/papers/24481846 | PubMed |
| 10 | 28391263 | Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway. | Cell Physiol Biochem | 2017 | https://conductscience.org/library/papers/28391263 | PubMed |
| 11 | 23095280 | Myosin light chain phosphorylation is critical for adaptation to cardiac stress. | Circulation | 2012 | https://conductscience.org/library/papers/23095280 | PubMed |
| 12 | 28164119 | Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28164119 | PubMed |
| 13 | 10655107 | Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. | Nat Med | 2000 | https://conductscience.org/library/papers/10655107 | PubMed |
| 14 | 28837147 | Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28837147 | PubMed |
| 15 | 28770953 | MicroRNA-200c exacerbates the ischemia/reperfusion injury of heart through targeting the glutaminase (GLS)-mediated glutamine metabolism. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28770953 | PubMed |
| 16 | 27443826 | Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation. | Sci Rep | 2016 | https://conductscience.org/library/papers/27443826 | PubMed |
| 17 | 18202317 | Identification of cardiac-specific myosin light chain kinase. | Circ Res | 2008 | https://conductscience.org/library/papers/18202317 | PubMed |
| 18 | 26334100 | The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. | Oncotarget | 2015 | https://conductscience.org/library/papers/26334100 | PubMed |
| 19 | 27565029 | miR-106a promotes cardiac hypertrophy by targeting mitofusin 2. | J Mol Cell Cardiol | 2016 | https://conductscience.org/library/papers/27565029 | PubMed |
| 20 | 25850725 | MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a. | J Cardiovasc Pharmacol | 2015 | https://conductscience.org/library/papers/25850725 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41235503 | The Network of Exosomes miRNA and p-MLC2 Regulatory Pathway Induced Pathological Cardiac Hypertrophy in Vasn Deficient Mice. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41235503 | PubMed |
| 40341377 | Divergent Cardiovascular Adaptations and Gene Regulation in High-Elevation Natives and Recent Colonizers of the Qinghai-Tibetan Plateau. | Mol Biol Evol | 2025 | https://conductscience.org/library/papers/40341377 | PubMed |
| 37395337 | Correction to Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. | J Cell Mol Med | 2023 | https://conductscience.org/library/papers/37395337 | PubMed |
| 35703318 | lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway. | Bioengineered | 2022 | https://conductscience.org/library/papers/35703318 | PubMed |
| 35384363 | Loss of cardiac myosin light chain kinase contributes to contractile dysfunction in right ventricular pressure overload. | Physiol Rep | 2022 | https://conductscience.org/library/papers/35384363 | PubMed |
| 35378949 | Myosin Light Chain Kinase Modulates to Improve Myocardial Hypoxia/Reoxygenation Injury. | J Healthc Eng | 2022 | https://conductscience.org/library/papers/35378949 | PubMed |
| 35348441 | MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1. | Bioengineered | 2022 | https://conductscience.org/library/papers/35348441 | PubMed |
| 34854218 | Vasorin deficiency leads to cardiac hypertrophy by targeting MYL7 in young mice. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/34854218 | PubMed |
| 34594408 | TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34594408 | PubMed |
| 34153234 | Amniotic fluid microRNA profiles in twin-twin transfusion syndrome with and without severe recipient cardiomyopathy. | Am J Obstet Gynecol | 2021 | https://conductscience.org/library/papers/34153234 | PubMed |
| 33748196 | Myocardial Infarction: The Protective Role of MiRNAs in Myocardium Pathology. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/33748196 | PubMed |
| 33732347 | Piperine protects against myocardial ischemia/reperfusion injury by activating the PI3K/AKT signaling pathway. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/33732347 | PubMed |
| 32575472 | MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32575472 | PubMed |
| 32468736 | Up-regulation of miR-195 contributes to cardiac hypertrophy-induced arrhythmia by targeting calcium and potassium channels. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32468736 | PubMed |
| 31929856 | The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31929856 | PubMed |
| 31840653 | Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22. | Med Sci Monit | 2019 | https://conductscience.org/library/papers/31840653 | PubMed |
| 31636246 | MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway. | Med Sci Monit | 2019 | https://conductscience.org/library/papers/31636246 | PubMed |
| 31547607 | MicroRNAs in Cardiac Hypertrophy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31547607 | PubMed |
| 30680929 | Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30680929 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| MIR200C | 406985 | PubTator's text mining | https://conductscience.org/library/genes/406985 | NCBI Gene |
| MYL2 | 4633 | PubTator's text mining | https://conductscience.org/library/genes/4633 | NCBI Gene |
| MYLK | 4638 | PubTator's text mining | https://conductscience.org/library/genes/4638 | NCBI Gene |
| MYLK3 | 91807 | PubTator's text mining | https://conductscience.org/library/genes/91807 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30680929
GET https://conductscience.org/api/papers/v1/30680929/references?page=2